This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,735.00, is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has an ultimate completion date of May 5, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,679.75, is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for the DLA, Defense...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a ceiling value of $14,976.85 and a period of performance through May 20, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a ceiling value of $32,784.81 and is set to run through July 1, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humulin R 500 unit/mL Kwikpen 3mL, a diabetes medication. The contract has a ceiling value of $3,268.99 and a period of performance through April 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a ceiling value of $10,085.89 and a completion date of May 29, 2025. It is a firm-fixed-price contract, indicating a predetermined payment amount. The contract is not designated as a set-aside, meaning it was competitively awarded. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a firm fixed price ceiling value of $16,068.72 and a period of performance through June 17, 2025. This contract is not designated as a set-aside, indicating open competition. AmerisourceBergen Drug...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $7,743.80. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, which are prescription diabetes medications. The contract has a performance period ending on July 16, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,080.20, is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract is designated as firm fixed price and has an ultimate completion date of July 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a ceiling value of $11,020.60 and is a firm fixed-price delivery order. It was awarded on June 9, 2025 with a performance period through June 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite...